Regulatory Considerations in the Development of Radiation-Drug Combinations
This article reviews the existing regulatory framework in which cancer drugs may be developed for use in combination with radiation therapy from the perspective of the US Food and Drug Administration (FDA).
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Amanda J. Walker Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Molecular Biology | Physics | Radiation Therapy | Radiology